Logo image
Methamphetamine Use and Cardiovascular Disease In Search of Answers
Journal article   Open access   Peer reviewed

Methamphetamine Use and Cardiovascular Disease In Search of Answers

Christopher G. Kevil, Nicholas E. Goeders, Matthew D. Woolard, Md Shenuarin Bhuiyan, Paari Dominic, Gopi K. Kolluru, Connie L. Arnold, James G. Traylor and A. Wayne Orr
Arteriosclerosis, thrombosis, and vascular biology, Vol.39(9), pp.1739-1746
09/01/2019
DOI: 10.1161/ATVBAHA.119.312461
PMCID: PMC6709697
PMID: 31433698
url
https://doi.org/10.1161/ATVBAHA.119.312461View
Published (Version of record) Open Access

Abstract

While the opioid epidemic has garnered significant attention, the use of methamphetamines is growing worldwide independent of wealth or region. Following overdose and accidents, the leading cause of death in methamphetamine users is cardiovascular disease, because of significant effects of methamphetamine on vasoconstriction, pulmonary hypertension, atherosclerotic plaque formation, cardiac arrhythmias, and cardiomyopathy. In this review, we examine the current literature on methamphetamine-induced changes in cardiovascular health, discuss the potential mechanisms regulating these varied effects, and highlight our deficiencies in understanding how to treat methamphetamine-associated cardiovascular dysfunction.
Cardiovascular System & Cardiology Hematology Life Sciences & Biomedicine Peripheral Vascular Disease Science & Technology

Details

Metrics

Logo image